Adamas Pharmaceuticals, Inc. ADMS
8.22 +8.22
Day range unavailable
52-week range unavailable
News
accesswire.com Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of Adamas Pharmaceuticals, Inc. (ADMS) Settlement Fund Before Deadline NEW YORK, NY / ACCESSWIRE / June 27, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com $4,650,000 Recovery from Adamas Pharmaceuticals, Inc. (ADMS). L&K, LLP Reminds Shareholders to File a Claim Before Deadline NEW YORK, NY / ACCESSWIRE / June 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com Deadline Approaching for Receiving Share of Adamas Pharmaceuticals, Inc. (ADMS) Recovery - Contact Levi & Korsinsky, LLP for Further Details NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:…
accesswire.com Deadline Approaching for Receiving Share of Adamas Pharmaceuticals, Inc. (ADMS) Recovery - Contact Levi & Korsinsky, LLP for Further Details NEW YORK, NY / ACCESSWIRE / June 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:…
accesswire.com Levi & Korsinsky, LLP Announces $4,650,000 Recovery for Adamas Pharmaceuticals, Inc. (ADMS). File Your Claim Before Deadline NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:…
accesswire.com Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) to File a Share in Class Action Recovery NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) to File a Share in Class Action Recovery NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc.…
accesswire.com Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:…
prnewswire.com Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMS OAKLAND, Calif. , May 13, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of California has approved the following…
marketwatch.com Lab-grown diamond maker Adamas One raises $11 mln in IPO Adamas One Corp. JEWL, said it priced 2.45 million shares at $4.50 a share for proceeds of $11 million in its initial public offering for trading on Friday on the Nasdaq. The Scottsdale, Ariz.
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the Firm NEW YORK, Oct. 28, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: FTS International, Inc. (NYSE: FTSI) concerning…
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations NEW YORK, Oct. 26, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
prnewswire.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMS NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 Upgrades
newsfilecorp.com SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Adamas Pharmaceuticals, Inc. with Supernus Pharmaceuticals, Inc. New York, New York--(Newsfile Corp. - October 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Adamas Pharmaceuticals, Inc.…
prnewswire.com Shareholder Alert: Ademi LLP investigates whether Adamas Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Supernus MILWAUKEE, Oct. 11, 2021 /PRNewswire/ -- Ademi LLP is investigating Adamas (Nasdaq: ADMS), for possible breaches of fiduciary duty and other violations of law in its transaction with Supernus. Click…
investorplace.com ADMS Stock Soars 70% Thanks to Adamas Pharmaceuticals Acquisition News ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million. The post ADMS Stock Soars 70% Thanks to Adamas Pharmaceuticals…
businesswire.com Adamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ADMS NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) to Supernus Pharmaceuticals, Inc. for…
benzinga.com Supernus Bolsters Parkinson's Portfolio With $450M Adamas Buyout: Highlights Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has agreed to acquire Adamas Pharmaceuticals Inc (NASDAQ: ADMS) for $9.10 per share, or $450 million. The deal consideration includes $8.10 per share in…- benzinga.com Earnings Scheduled For August 9, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
benzinga.com Earnings Scheduled For May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.
benzinga.com 102 Biggest Movers From Yesterday Gainers Leisure Acquisition Corp. (NASDAQ: LACQ) shares jumped 111.2% to close at $23.99 on Monday after the company entered into a merger agreement for business combination with Ensysce Biosciences,…
benzinga.com Stocks That Hit 52-Week Highs On Monday Before 10 a.m. ET on Monday, 79 stocks hit new 52-week highs.
benzinga.com Earnings Scheduled For November 5, 2020 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.- benzinga.com 56 Biggest Movers From Friday Gainers Nano-X Imaging Ltd. (NASDAQ: NNOX) shares gained 32.9% to close at $64.19. Nano X Imaging recently announced it has signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC…
benzinga.com 33 Stocks Moving in Monday's Pre-Market Session Gainers SuperCom Ltd. (NASDAQ: SPCB) rose 188.5% to $3.65 in pre-market trading after surging 12% on Friday.- benzinga.com 96 Biggest Movers From Friday Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the company reported FUEL CHEM® demonstration orders from two new industrial power customers.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Wednesday
benzinga.com 80 Biggest Movers From Friday - benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com 52 Biggest Movers From Yesterday
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
- benzinga.com Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
- benzinga.com 74 Biggest Movers From Friday
- benzinga.com 64 Stocks Moving In Friday's Mid-Day Session
- benzinga.com Stocks Which Set New 52-Week Low Friday, October 5th
- benzinga.com 40 Biggest Movers From Yesterday
- benzinga.com 40 Biggest Movers From Yesterday
- benzinga.com 35 Stocks Moving In Monday's Mid-Day Session
benzinga.com 30 Stocks Moving In Monday's Pre-Market Session - benzinga.com 18 Biggest Mid-Day Gainers For Friday
- benzinga.com 22 Stocks Moving In Friday's Pre-Market Session